Customized strain engineering services to evaluate Pseudomonas putida for production of biochemicals, proteins, or environmental remediation.
We provide integrated design-build-test-learn workflows tailored to your target molecule, leveraging the natural metabolic versatility of Pseudomonas putida for robust industrial performance.
We combine rational pathway engineering with directed evolution and high-throughput screening to develop Pseudomonas putida strains that meet your production goals.
We design targeted modifications to metabolic pathways in P. putida to evaluate flux toward your product of interest. This includes gene knockouts, knock-ins, and promoter tuning.
For complex traits, we generate diverse mutant libraries using error-prone PCR or transposon mutagenesis and screen for improved production or degradation.
Iterative cycles of strain design, construction, screening, and analysis to progressively evaluate performance.
Quantitative product analysis using HPLC, GC-MS, or other methods; growth monitoring and metabolite profiling.
Evaluation of plasmid retention, genomic integrity, and strain purity to support consistent performance over generations.
Each project includes a comprehensive handoff package with engineered strains and supporting data.
Projects are tailored to your specific target and requirements. Typical scoping parameters include:
| Parameter | Typical project scope |
|---|---|
| Host Strain | ATCC or proprietary P. putida backgrounds (e.g., KT2440, ATCC 12633) as specified |
| Engineering Strategy | Rational design (gene knockout/insertion), combinatorial mutagenesis, or targeted CRISPR-based editing, defined per project |
| Screening Method | Scoped per project after consultation |
| Analytical Method | HPLC, GC-MS, UV-vis spectrophotometry, or enzymatic assays as required for your product |
| Scale-Up Depth | Shake-flask to bench-top bioreactor (up to 5 L) included when scoped; larger scale upon request |
| QC Checks | Genetic stability (plasmid retention, genome integrity), purity |
| Project Duration | Defined during project scoping based on target complexity and number of engineering cycles |
Our strain development process follows a structured design-build-test-learn flow to support efficient delivery.
We review your target compound, desired production metrics, and timeline to select the appropriate P. putida base strain and define the engineering strategy.
Our team designs a tailored approach including gene knockouts, heterologous pathway integration, or library construction, with in silico analysis to prioritize modifications.
We construct the engineered strains using established methods (allelic exchange, CRISPR/Cas, or transposon mutagenesis) and generate screening libraries as planned.
Libraries or individual clones are screened using plate-based assays for product yield or degradation activity. Top hits are confirmed and may be advanced to further engineering cycles.
Final selected strains are fully characterized for growth, production, stability, and purity. A deliverable package with strains, data, and documentation is provided.
Pseudomonas putida is a versatile host for a range of industrial and environmental applications.
Develop P. putida strains for high-yield production of biofuels, bioplastics monomers, amino acids, or other value-added chemicals from renewable feedstocks.
Engineer P. putida strains with enhanced ability to degrade pollutants such as hydrocarbons, pesticides, or industrial chemicals in environmental applications.
Evaluate P. putida as a host for recombinant protein or enzyme expression, leveraging its high tolerance to solvents and low protease background.
Common questions about our Pseudomonas putida strain development service.
We work with commonly used laboratory strains such as P. putida KT2440, ATCC 12633, and other ATCC backgrounds. Customers may also provide their own proprietary strains for engineering, subject to viability assessment.
Screening methods are tailored to the target: we use growth-coupled assays, fluorescent reporters, or direct product quantification (HPLC/GC-MS) depending on the molecule. Library sizes and screening depth are scoped per project to balance throughput and cost.
Yes, scale-up from shake-flask to bench-top bioreactor (up to 5 L) is available as an optional add-on. Larger-scale feasibility studies can be discussed during project scoping.
Each engineered strain undergoes genetic stability checks (including plasmid retention and genome integrity), purity verification, and reproducible performance testing over at least three sequential passages. A Certificate of Analysis accompanies each deliverable.
Get a customized quote for your Pseudomonas putida Strain Development and Screening Services project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.